McKesson Corporation
MCK
Rank in Stocks
#189
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Share Price
$1,011.60
Last synced: 2026-10-19
Market Cap
$117.94B
Change (1 day)
0.64%
Change (1 year)
28.40%
Country
US
Trade McKesson Corporation (MCK)
Category
Healthcare
P/E ratio for McKesson Corporation (MCK)
P/E ratio as of October 2026 TTM: 26.02
According to McKesson Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 26.02. At the end of 2024 the company had a P/E ratio of 23.80.
P/E ratio history for McKesson Corporation from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 26.02 | 0.00% |
| 2025 | 26.02 | 9.31% |
| 2024 | 23.80 | 68.68% |
| 2023 | 14.11 | -66.28% |
| 2022 | 41.85 | -706.47% |
| 2021 | -6.90 | -125.37% |
| 2020 | 27.20 | -96.04% |
| 2019 | 686.13 | 56.89% |
| 2018 | 437.33 | 6,817.88% |
| 2017 | 6.32 | -60.53% |
| 2016 | 16.02 | -54.95% |
| 2015 | 35.55 | 11.06% |
| 2014 | 32.01 | 68.89% |
| 2013 | 18.96 | 23.18% |
| 2012 | 15.39 | -14.73% |
| 2011 | 18.05 | 28.94% |
| 2010 | 14.00 | 19.55% |
| 2009 | 11.71 | -23.94% |
| 2008 | 15.39 | -15.02% |
| 2007 | 18.12 | -16.19% |
| 2006 | 21.61 | -130.58% |
| 2005 | -70.69 | -623.74% |
| 2004 | 13.50 | 3.94% |
| 2003 | 12.99 | -49.58% |
| 2002 | 25.75 | -116.43% |
| 2001 | -156.79 | -2,020.83% |
| 2000 | 8.16 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| - | - |
US
|
|
| 34.08 | 30.96% |
US
|
|
| - | - |
US
|
|
| 45.62 | 75.31% |
AU
|
|
| 24.73 | -4.97% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.